STEQEYMA

USTEKINUMAB-STBA · CELLTRION USA, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for STEQEYMA, covering 2024-12-17 to 2026-04-16. Get the full timeline:

Most recent: EMA Authorised: Steqeyma (ustekinumab) — Celltrion Healthcare Hungary Kft.